Journals / Türk Beyin Damar Hastalıkları Dergisi / 2000 / Cilt: 6 - Sayı: 3

Disseminated cerebral venous thrombosis due to essential thrombocythemia

Esansiyel trombositemiye bağlı yaygın serebral venöz tromboz

Pages
77–79
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Laboratory findings revealed that the hemoglobin concentration was 17.1 g/dl, the hematocrit was 48.4%, the WBC count was 28 500 /mm<sup>3</sup>, the platelet count was 674000/ mm<sup>3</sup>.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Various factors were shown about the etiology of cerebral venous thrombosis and hypercoagulopathy plays a very important role among these factors.
📊
Key Findings & Data:In this study, we described a 34 year-old woman who had nausea, vomiting and gradually increasing headache for a month.
💡
Conclusion & Impact:Laboratory findings revealed that the hemoglobin concentration was 17.1 g/dl, the hematocrit was 48.4%, the WBC count was 28 500 /mm<sup>3</sup>, the platelet count was 674000/ mm<sup>3</sup>.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Trombofili · Erişkin · Baş ağrısı

Abstract

Various factors were shown about the etiology of cerebral venous thrombosis and hypercoagulopathy plays a very important role among these factors. In this study, we described a 34 year-old woman who had nausea, vomiting and gradually increasing headache for a month. Neurological evaluation was normal except for bilateral grade IV papiloedema. Neuroradiological investigation demonstrated complete thrombosis of the superior sagittal sinus, confluent sinium, transvers and sigmoid sinuses bilaterally. Laboratory findings revealed that the hemoglobin concentration was 17.1 g/dl, the hematocrit was 48.4%, the WBC count was 28 500 /mm<sup>3</sup>, the platelet count was 674000/ mm<sup>3</sup>. Bone marrow biopsy was performed and essential thrombocythemia was diagnosed. The patient has been maintained on anticoagulant and ribonucleotide reductase inhibitor. In the literature disseminated venous thrombosis as seen in our patient was rarely reported. Hematological diseases, endocrinological disorders and anatomical variations are reported as etiological factors.

Özet

Serebral venöz tromboz etyolojisinde birçok neden bulunmakla birlikte, hiperkoagulabilite önemli rol oynamaktadır. Bu çalışmada son bir aydır giderek artan başağrısı, bulantı, kusma nedeni ile servisimize yatan, daha önce hiçbir yakınması olmayan 34 yaşındaki bayan hasta bildirilmiştir. Hastanın yapılan nörolojik muayenesinde bilateral grade IV papil ödem mevcut olup, nöroradyolojik inceleme sonucunda yaygın (superior sagittal sinüs, konfluen sinium, her iki transvers ve sigmoid sinüsler) serebral venöz tromboz tespit edilmiştir. Tam kan sayımında Hb 17.1 g/dl, Hct % 48.4, Lökosit 28 500 /mm 3 , Plt 674 000 /mm 3 bulunması nedeni ile yapılan kemik iliği incelemesinde hastaya esansiyel trombositemi tanısı konmuş olup, antikoagulan tedavi yanısıra ribonükleotid redüktaz inhibitörü de tedaviye eklenmiştir. Literatürde olgumuzda olduğu gibi yaygın serebral venöz tromboz olguları nadiren bildirilmiş olup, bazı hematolojik hastalıkların, endokrin bozuklukların ve anatomik varyasyonların etyolojide yer alabileceği ifade edilmiştir.

🔖

Cite This Article

TURGUT, N., AYDIN, N., ÇELİK, Y., TURGUT, B., DEMİR, M., UTKU, U., VURAL, Ö. (2000). Disseminated cerebral venous thrombosis due to essential thrombocythemia. Türk Beyin Damar Hastalıkları Dergisi, Cilt: 6 - Sayı: 3, 77–79. https://ajindex.com/articles/409151

References (1)

  1. Bousser MC, Barnett HJM. Cerebral venous thrombosis. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM (Eds) Stroke pathophysiology, diagnosis, and management. 2nd edition. New York Churchill Livingstone Inc., 1992;19:517-537 2. Bousser MG, Chiras J, Sauron B: Cerebral venous thrombosis; a revîew of 38 cases. Stroke 1985;16:199 3. Gabrielseen TO, Seeger JF, Knake JE: Radiology of cerebral vein occlusion without dural sinüs occlusion. Radiology 1981;140:403 4. Virapongse C, Cazenave C, Quisling R: The empty delta sign: frequency and significance in 76 cases of dural sinüs thrombosis. Radiology 1987;162:779 5. Levine SP.Thrombocytosis. In: Lee GR, Foerster J, Lukens J,Parakevas F,Greer JP, Rodgers GM(Eds).Wintrobe(s Clinical Hematology,10 th edition.Volume 2.Baltimore:Mass Publishing Co.,1999;66:1648-1660 6. Tefferi A, Hoagland HC. Issues in the diagnosis and management of essential thrombocythemia.Mayo Clin Proc 1994;69;651-655 7. Kurzrock R, Coheen PR. Erythromelalgia: review of clinical characteristics and pathophysiology. Am J Med 1991; 91:416-422 8. Michiels JJ, Kaudstaal PJ, Mulder AH. Transient neurologic and ocular manifestations in primary thrombocythemia. Neurology 1993;43:1107-1110 9. Arboix A, Besses C, Acın P. Ischemic stroke as a first manifestation of essential thrombocythemia. Stroke 1995;26:1463-1466 10. Schutta HS, Williams EC, Baranski BG: Cerebral Venous Thrombosis with Plasminogen Deficiency.Stoke 1991;22;401-405 11. Larkey D, Williams CR, Fanning J, Hilgers RD, Graham DR,Fortin CJ.Fatal superior sagittal sinus thrombosis associated with internal jugular vein catheterization.Am J Obstet Gynecol 1993;169;1612-1614 12. Nonami Y, Sasahashi N, Satoh K, Ogoshi S, Tamiya T. A case report:mitral valve replacement for the patient with essential thrombocythemia.Nippon Kyobu Geka Zasshi 1993 Sep;41(9):1567-72 13. Perez-Encinas M, Bello JL, Perez-Crespo S, De Miguel R,Tome S.Familial myeloproliferative syndrome.Am J Hematol 1994 Jul;46(3);225-9 14. Raizer J], DeAngelis LM. Cerebral sinüs thrombosis diagnosed by MRI and MR venography in cancer patients.Neurology 2000;54:1222-1226